Heparin II domain of fibronectin mediates contractility through an α4β1 co-signaling pathway

Experimental Cell Research

Volumn 316, Issue 9, 2010, Pages 1500-1512

  Schwinn, Marie K ^a   Gonzalez, Jose M ^a   Gabelt, B'Ann T ^a   Sheibani, Nader ^a   Kaufman, Paul L ^a   Peters, Donna M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Actin cytoskeleton; Contractility; Heparin II domain; Integrins; Trabecular meshwork

Indexed keywords

ACTIN; COLLAGEN; FIBRONECTIN; HEPARIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEOHEPARAN SULFATE; SMALL INTERFERING RNA; SYNDECAN; SYNDECAN 4; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 4;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; AQUEOUS HUMOR FLOW; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK;

EID: 77952891525     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.03.010     Document Type: Article

References (59)

1. Tian B., Kaufman P.L., Volberg T., Gabelt B.T., Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch. Ophthalmol. 1998, 116:633-643.
2. Peterson J.A., Tian B., Bershadsky A.D., Volberg T., Gangnon R.E., Spector I., Geiger B., Kaufman P.L. Latrunculin-A increases outflow facility in the monkey. Invest. Ophthalmol. Vis. Sci. 1999, 40:931-941.
3. Peterson J.A., Tian B., Geiger B., Kaufman P.L. Effect of latrunculin-B on outflow facility in monkeys. Exp. Eye Res. 2000, 70:307-313.
4. Sanka K., Maddala R., Epstein D.L., Rao P.V. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:2105-2114.
5. Rao P.V., Deng P., Sasaki Y., Epstein D.L. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp. Eye Res. 2005, 80:197-206.
6. Rao P.V., Deng P., Maddala R., Epstein D.L., Li C.Y., Shimokawa H. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol. Vis. 2005, 11:288-297.
7. Rao P.V., Deng P.F., Kumar J., Epstein D.L. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 2001, 42:1029-1037.
8. Khurana R.N., Deng P.F., Epstein D.L., Vasantha Rao P. The role of protein kinase C in modulation of aqueous humor outflow facility. Exp. Eye Res. 2003, 76:39-47.
9. Legate K.R., Wickstrom S.A., Fassler R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev. 2009, 23:397-418.
10. Morgan M.R., Humphries M.J., Bass M.D. Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 2007, 8:957-969.
11. Moser M., Legate K.R., Zent R., Fassler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899.
12. Humphries J.D., Schofield N.R., Mostafavi-Pour Z., Green L.J., Garratt A.N., Mould A.P., Humphries M.J. Dual functionality of the anti-beta1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors. J. Biol. Chem. 2005, 280:10234-10243.
13. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990, 60:577-584.
14. Li Z., Calzada M.J., Sipes J.M., Cashel J.A., Krutzsch H.C., Annis D.S., Mosher D.F., Roberts D.D. Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior. J. Cell Biol. 2002, 157:509-519.
15. Newham P., Craig S.E., Seddon G.N., Schofield N.R., Rees A., Edwards R.M., Jones E.Y., Humphries M.J. Alpha4 integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J. Biol. Chem. 1997, 272:19429-19440.
16. Bayless K.J., Meininger G.A., Scholtz J.M., Davis G.E. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci. 1998, 111(Pt 9):1165-1174.
17. Humphries J.D., Humphries M.J. CD14 is a ligand for the integrin alpha4beta1. FEBS Lett. 2007, 581:757-763.
18. Guan J.L., Hynes R.O. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell 1990, 60:53-61.
19. Mould A.P., Komoriya A., Yamada K.M., Humphries M.J. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J. Biol. Chem. 1991, 266:3579-3585.
20. Moyano J.V., Carnemolla B., Dominguez-Jimenez C., Garcia-Gila M., Albar J.P., Sanchez-Aparicio P., Leprini A., Querze G., Zardi L., Garcia-Pardo A. Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins. J. Biol. Chem. 1997, 272:24832-24836.
21. Liao Y.F., Gotwals P.J., Koteliansky V.E., Sheppard D., Van De Water L. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 2002, 277:14467-14474.
22. Sharma A., Askari J.A., Humphries M.J., Jones E.Y., Stuart D.I. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J. 1999, 18:1468-1479.
23. Bloom L., Ingham K.C., Hynes R.O. Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol. Biol. Cell 1999, 10:1521-1536.
24. Barkalow F.J., Schwarzbauer J.E. Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 1991, 266:7812-7818.
25. Woods A., McCarthy J.B., Furcht L.T., Couchman J.R. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell 1993, 4:605-613.
26. Oh E.S., Woods A., Couchman J.R. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J. Biol. Chem. 1997, 272:11805-11811.
27. Dovas A., Yoneda A., Couchman J.R. PKCbeta-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J. Cell Sci. 2006, 119:2837-2846.
28. Gonzalez J.M., Faralli J.A., Peters J.M., Newman J.R., Peters D.M. Effect of heparin II domain of fibronectin on actin cytoskeleton and adherens junctions in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:2924-2931.
29. Gonzalez J.M., Hu Y., Gabelt B.T., Kaufman P.L., Peters D.M. Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments. Invest. Ophthalmol. Vis. Sci. 2009, 50:235-241.
30. Filla M.S., David G., Weinreb R.N., Kaufman P.L., Peters D.M. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp. Eye Res. 2004, 79:61-74.
31. Peterson J.A., Sheibani N., David G., Garcia-Pardo A., Peters D.M. Heparin II domain of fibronectin uses alpha4beta1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J. Biol. Chem. 2005, 280:6915-6922.
32. Filla M.S., Liu X., Nguyen T.D., Polansky J.R., Brandt C.R., Kaufman P.L., Peters D.M. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest. Ophthalmol. Vis. Sci. 2002, 43:151-161.
33. Bultmann H., Santas A.J., Peters D.M. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J. Biol. Chem. 1998, 273:2601-2609.
34. David G., Bai X.M., Van der Schueren B., Cassiman J.J., Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 1992, 119:961-975.
35. Hu Y., Gabelt B.T., Kaufman P.L. Monkey organ-cultured anterior segments: technique and response to H-7. Exp. Eye Res. 2006, 82:1100-1108.
36. Santas A.J., Bahler C., Peterson J.A., Filla M.S., Kaufman P.L., Tamm E.R., Johnson D.H., Peters D.M. Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 2003, 44:4796-4804.
37. Woods A., Longley R.L., Tumova S., Couchman J.R. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 2000, 374:66-72.
38. Echtermeyer F., Baciu P.C., Saoncella S., Ge Y., Goetinck P.F. Syndecan-4 core protein is sufficient for the assembly of focal adhesions and actin stress fibers. J. Cell Sci. 1999, 112(Pt 20):3433-3441.
39. Farley J.R., Nakayama G., Cryns D., Segel I.H. Adenosine triphosphate sulfurylase from Penicillium chrysogenum equilibrium binding, substrate hydrolysis, and isotope exchange studies. Arch. Biochem. Biophys. 1978, 185:376-390.
40. Humphries D.E., Silbert J.E. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem. Biophys. Res. Commun. 1988, 154:365-371.
41. Altevogt P., Hubbe M., Ruppert M., Lohr J., von Hoegen P., Sammar M., Andrew D.P., McEvoy L., Humphries M.J., Butcher E.C. The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1. J. Exp. Med. 1995, 182:345-355.
42. Mould A.P., Askari J.A., Barton S., Kline A.D., McEwan P.A., Craig S.E., Humphries M.J. Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain. J. Biol. Chem. 2002, 277:19800-19805.
43. Mould A.P., Garratt A.N., Puzon-McLaughlin W., Takada Y., Humphries M.J. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem. J. 1998, 331(Pt 3):821-828.
44. Rose D.M., Alon R., Ginsberg M.H. Integrin modulation and signaling in leukocyte adhesion and migration. Immunol. Rev. 2007, 218:126-134.
45. Tian B., Gabelt B.T., Geiger B., Kaufman P.L. The role of the actomyosin system in regulating trabecular fluid outflow. Exp. Eye Res. 2009, 88:713-717.
46. Kuhn K. Basement membrane (type IV) collagen. Matrix Biol. 1995, 14:439-445.
47. Acott T.S., Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 2008, 86:543-561.
48. Moyano J.V., Maqueda A., Casanova B., Garcia-Pardo A. Alpha4beta1 integrin/ligand interaction inhibits alpha5beta1-induced stress fibers and focal adhesions via down-regulation of RhoA and induces melanoma cell migration. Mol. Biol. Cell 2003, 14:3699-3715.
49. Porter J.C., Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function. J. Cell Biol. 1997, 138:1437-1447.
50. Hikita S.T., Cann G.M., Wingerd K.L., Mullick L.H., Wayne W.C., Webb S.W., Clegg D.O. Integrin alpha4beta1 (VLA-4) expression and activity in retinal and peripheral neurons. Mol. Cell. Neurosci. 2003, 23:427-439.
51. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 2001, 60:1645-1657.
52. Duplaa C., Couffinhal T., Dufourcq P., Llanas B., Moreau C., Bonnet J. The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ. Res. 1997, 80:159-169.
53. Mould A.P., Humphries M.J. Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J. 1991, 10:4089-4095.
54. Askari J.A., Buckley P.A., Mould A.P., Humphries M.J. Linking integrin conformation to function. J. Cell Sci. 2009, 122:165-170.
55. Mostafavi-Pour Z., Askari J.A., Parkinson S.J., Parker P.J., Ng T.T., Humphries M.J. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J. Cell Biol. 2003, 161:155-167.
56. Santas A.J., Peterson J.A., Halbleib J.L., Craig S.E., Humphries M.J., Peters D.M. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading. J. Biol. Chem. 2002, 277:13650-13658.
57. Iida J., Meijne A.M., Oegema T.R., Yednock T.A., Kovach N.L., Furcht L.T., McCarthy J.B. A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J. Biol. Chem. 1998, 273:5955-5962.
58. Filla M.S., Schwinn M.K., Sheibani N., Kaufman P.L., Peters D.M. Distinct {beta}1 and {beta}3 integrin pathways converge to regulate cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells. Invest. Ophthalmol. Vis. Sci. 2009.
59. Rose D.M. The role of the alpha4 integrin-paxillin interaction in regulating leukocyte trafficking. Exp. Mol. Med. 2006, 38:191-195.